Experience

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering of senior notes by Ingersoll-Rand Global…

Davis Polk is advising Temenos Group AG in connection with its £1.4 billion recommended cash offer to acquire the entire share capital of Fidessa group plc. Fidessa shareholders will…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered offering by Celgene Corporation of $500 million aggregate…

On February 8, 2018, the New York Appellate Division, First Department (the “Appellate Division”), granted dismissal of a judgment enforcement action following an appeal brought by Davis…

Davis Polk advised the initial purchasers on a Rule 144A offering by Avadel Finance Cayman Limited, a wholly owned subsidiary of Avadel Pharmaceuticals plc, of $143.7 million aggregate…

Davis Polk is advising Equinix, Inc. on its acquisition of the Infomart Dallas from ASB Real Estate in an $800 million debt and cash transaction. The acquisition is expected to close in mid…

Davis Polk advised Affimed N.V. on its $26.5 million public offering of 13,225,000 of its common shares. Included in the shares are 1,725,000 shares sold by Affimed pursuant to the…

Davis Polk advised EnVen Energy Corporation in connection with a Rule 144A/Regulation S offering of $325 million aggregate principal amount of its 11.000% senior secured second-lien notes…

Davis Polk is advising PricewaterhouseCoopers LLP on the sale of its U.S. Public Sector business to Veritas Capital. The transaction is subject to regulatory approvals and other conditions…

Davis Polk is advising Roche on its $1.9 billion acquisition of Flatiron Health, Inc. The transaction, which is expected to close in the first half of 2018, is subject to customary closing…